Ilypsa
Santa Clara
About Ilypsa
It discovers and develops renal care pharmaceutical products. It develops non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. The company, formerly known as Symyx Therapeutics, Inc. was founded in 2002 and is based in Santa Clara, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $44.0M
- Funding stage: M&A
- Last round: Series B (Jul 2005)
- Website: ilypsa.com
- Phone: 408-215-2800
Industries & Categories
Biotechnology, Manufacturing, Medical
Canonical: https://fsome.com/organization/ilypsa-1908676 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.